Funding

Estrigenix Therapeutics

United States · Biotech · Enterprise software

Developing selective estrogen receptor-beta therapeutics for women's health and neurodegenerative diseases

Visit estrigenix.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Seed$2MTalents Fund I — Role not disclosed

Investors

Talents Fund ISeed

Coverage

Jul 21, 2026Estrigenix Therapeutics · Seed

Similar companies

Knowledge WorkTokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.¥4.8B · Series C debt second close
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesestrigenix.com ↗